Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer

INTRODUCTION: Tamoxifen is the most widely prescribed anti-estrogen treatment for patients with estrogen receptor (ER)-positive breast cancer. However, there is still a need for biomarkers that reliably predict endocrine sensitivity in breast cancers and these may well be expressed in a dynamic mann...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Karen J, Sims, Andrew H, Liang, Liang, Faratian, Dana, Muir, Morwenna, Walker, Graeme, Kuske, Barbara, Dixon, J Michael, Cameron, David A, Harrison, David J, Langdon, Simon P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917034/
https://www.ncbi.nlm.nih.gov/pubmed/20569502
http://dx.doi.org/10.1186/bcr2593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917034/
https://www.ncbi.nlm.nih.gov/pubmed/20569502
http://dx.doi.org/10.1186/bcr2593

Ejemplares similares